Macquarie Group LTD Dr Reddys Laboratories LTD Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Macquarie Group LTD holds 3,891 shares of RDY stock, worth $52,917. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,891
Previous 390
897.69%
Holding current value
$52,917
Previous $30,000
103.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$156 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$153 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$137 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$128 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$76.3 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.26B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...